Considering the high risk of recurrence in patients with LNP prostate cancer and the scarcity of relevant studies analyzing LNP prostate cancer patients after RP, further research of salvage treatment may be more important in patients with BCR or persistent elevated PSA. The gene discussed is KLK3; the disease is prostate carcinoma.